MD PhD DDS BSc MSc FDSRCS
Dr Anna Patrikidou is a consultant in medical oncology and the Associate Medical Director at the Sarah Cannon Research Institute, as well as an Honorary Senior Clinical Lecturer at the UCL Cancer Institute. She specialises in early and late phase clinical trials (drug development).
Dr Patrikidou received her medical oncology training at the acclaimed Gustave Roussy Institute in Paris, France. She has extensive basic and transnational research with undergraduate and postgraduate education and training received in London (University College London, Institute of Cancer Research/Royal Marsden Hospital), France and Greece. Prior to joining SCRI, she was a Consultant Medical Oncologist at the Geneva University Hospital, Switzerland, where she was also involved in drug development, with a specific focus on cancer immunotherapy.
Dr Patrikidou has substantial clinical research (early and late phase clinical trials) experience in several European countries, and has been a Principal Investigator in numerous Phase I-IV oncology clinical trials, with a special interest in immuno-oncology. She is a member of several large research organisations, including the European Society of Medical Oncology (ESMO) and the European Organisation for Research and Treatment of Cancer (EORTC), and has acted as a Scientific Committee member for several oncological congresses, including the ESMO Annual Congress. She has presented her work in multiple national and international congresses, and has a significant body of scientific publications, along with an extensive network of active international collaborations in clinical research.